Insider Transactions in Q4 2021 at Becton Dickinson & CO (BDX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2021
|
Betty D Larson EVP HR & CHRO |
SELL
Open market or private sale
|
Direct |
3,341
-19.1%
|
$851,955
$255.0 P/Share
|
|
Dec 16
2021
|
Betty D Larson EVP HR & CHRO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
341
-3.57%
|
$86,955
$255.0 P/Share
|
|
Dec 16
2021
|
Betty D Larson EVP HR & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
893
+8.55%
|
$86,621
$97.14 P/Share
|
|
Dec 07
2021
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Open market or private sale
|
Direct |
233
-17.76%
|
$58,250
$250.0 P/Share
|
|
Nov 26
2021
|
James C Lim Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
893
+4.14%
|
-
|
|
Nov 26
2021
|
Christopher Del Orefice EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,608
+27.24%
|
-
|
|
Nov 26
2021
|
Antoine C Ezell EVP, President Americas & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
758
+8.45%
|
-
|
|
Nov 26
2021
|
David Hickey EVP & President, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,473
+22.55%
|
-
|
|
Nov 26
2021
|
Thomas J Spoerel SVPController & Chief Acct Off |
BUY
Grant, award, or other acquisition
|
Direct |
489
+16.08%
|
-
|
|
Nov 26
2021
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Payment of exercise price or tax liability
|
Direct |
195
-15.98%
|
-
|
|
Nov 26
2021
|
Christopher R Reidy CFO and EVP of Administration |
BUY
Grant, award, or other acquisition
|
Direct |
4,998
+7.5%
|
-
|
|
Nov 26
2021
|
Christopher R Reidy CFO and EVP of Administration |
SELL
Payment of exercise price or tax liability
|
Direct |
1,132
-3.81%
|
-
|
|
Nov 26
2021
|
Betty D Larson EVP HR & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,656
+13.75%
|
-
|
|
Nov 26
2021
|
Betty D Larson EVP HR & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
580
-7.81%
|
-
|
|
Nov 26
2021
|
Ribo Alberto Mas EVP and Pres, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
3,802
+14.69%
|
-
|
|
Nov 26
2021
|
Ribo Alberto Mas EVP and Pres, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
798
-7.71%
|
-
|
|
Nov 26
2021
|
Samrat S. Khichi EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,904
+19.81%
|
-
|
|
Nov 26
2021
|
Samrat S. Khichi EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-13.43%
|
-
|
|
Nov 26
2021
|
Alexandre Conroy EVP of Integrated Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
2,535
+5.68%
|
-
|
|
Nov 26
2021
|
Alexandre Conroy EVP of Integrated Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
863
-4.15%
|
-
|
|
Nov 26
2021
|
Roland Goette EVP and President, EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
937
+4.43%
|
-
|
|
Nov 26
2021
|
Roland Goette EVP and President, EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
31
-0.32%
|
-
|
|
Nov 26
2021
|
Simon D Campion EVP and Segment President |
BUY
Grant, award, or other acquisition
|
Direct |
2,775
+12.0%
|
-
|
|
Nov 26
2021
|
Simon D Campion EVP and Segment President |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-6.87%
|
-
|
|
Nov 26
2021
|
Thomas E Polen Jr Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
13,369
+19.47%
|
-
|
|
Nov 26
2021
|
Thomas E Polen Jr Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,913
-9.47%
|
-
|
|
Nov 16
2021
|
Roland Goette EVP and President, EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
1,914
-16.96%
|
$467,016
$244.11 P/Share
|
|
Nov 16
2021
|
Roland Goette EVP and President, EMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
3,055
+21.3%
|
$219,960
$72.12 P/Share
|
|
Oct 21
2021
|
Carrie L Byington Director |
BUY
Grant, award, or other acquisition
|
Direct |
221
+50.0%
|
-
|